Advertisement

Molecular Biotechnology

, Volume 34, Issue 2, pp 151–156 | Cite as

Toward more efficient protein expression

Keep the message simple
Research

Abstract

Optimization of gene coding-sequence, including preferred codon usage and removal of cryptic splice sites and mRNA-destabilizing motifs, has been shown to improve recombinant protein production of different proteins. Here, we present data to show that gene optimization can also be used to improve the production of a complex macromolecule, namely an antibody. When applied to the heavy and light chain genes of our model antibody, we found that greater numbers of high-producing transfectants as well as increased levels of protein production were observed (≈1.5-fold). In this test model, production was improved even though the antibody has previously been demonstrated to give high expression in stably transfected cells (up to 5 g/L in bioreactors). Because the parental heavy chain sequence contained introns, and the process of gene optimization is most efficiently performed on sequences without introns, we demonstrated that removal of introns in the coding sequence had no effect on the quantity of antibody produced. All constructs were evaluated using Lonza's glutamine synthetase gene expression vectors in Chinese hamster ovary cells. Our findings suggest that significant improvements in product yields can be achieved by gene optimization, which may facilitate the processing and translation of gene transcripts.

Index Entries

Glutamine synthetase Chinese hamster ovary mRNA transcription translation codon optimization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Birch, J. R., Mainwaring, D. O., and Racher, A. J. (2005), Use of the glutamine synthetase (GS) expression system for the rapid development of highly productive mammalian cell processes, in Modern Biopharmaceuticals (Knäblein, J., ed.) WILEY-VCH Verlag GmbH & Co. KGaA. Weinheim, pp. 809–832.Google Scholar
  2. 2.
    Rotondaro, L., Mele, A., and Rovera, G., (1996), Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3′-untranslated sequences. Gene 168, 195–198.PubMedCrossRefGoogle Scholar
  3. 3.
    Angelichio, M. L., Beck, J. A., Johansen, H., and Ivey-Hoyle, M. (1991), Comparison of several promoters and polyadenylation signals for use in heterologous gene expression in cultured Drosophila cells. Nucleic Acids Res. 19, 5037–5043.PubMedCrossRefGoogle Scholar
  4. 4.
    Xu, Z. L., Mizuguchi, H., Ishii-Watabe, A., Uchida, E., Mayumi, T., and Hayakawa, T. (2002), Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J. Control Release 81, 155–163.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim, D., Kim, J. D., Baek, K., Yoon, Y., and Yoon, J. (2003) Improved mammalian expression systems by manipulating transcriptional termination regions. Biotechnol. Prog. 19, 1620–1622.PubMedCrossRefGoogle Scholar
  6. 6.
    Benton, T., Chen, T., McEntee, M., et al. (2002) The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large scale quantities of protein. Cytotechnol. 38, 43–46.CrossRefGoogle Scholar
  7. 7.
    Kim, J.-M., Kim, J.-S., Park, D.-H., et al. (2004) Improved recombinant gene expression in CHO cells using matrix attachment regions. J. Biotechnol. 107, 95–105.PubMedCrossRefGoogle Scholar
  8. 8.
    Girod, P.-A., Zahn-Zabal, M., and Mermod, N. (2005), Use of the chicken lysozyme 5′ matrix attachement region to generate high producer CHO cell lines. Biotechnol. Bioeng. 5, 1–11.CrossRefGoogle Scholar
  9. 9.
    Kalwy, S., Rance, J., Norman, A, and Gay, R. (2005) Towards stronger gene expression: a promoter's story. Proc. 19th ESACT Meeting, in press. AU please update ref. 9Google Scholar
  10. 10.
    Smales, C. M., Dinnis, D. M., Stansfield, S. H., et al. (2004) Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol. Bioeng., 88, 474–488.PubMedCrossRefGoogle Scholar
  11. 11.
    Barnes, L. M., Bentley, C. M., and Dickson, A. J. (2004), Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol. Bioeng. 85, 115–121.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim, N. S., Kim, S. J., and Lee, G. M. (1998). Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. Biotechnol. Bioeng. 60, 679–688.PubMedCrossRefGoogle Scholar
  13. 13.
    Dinnis, D. M. and James, D. C. (2005), Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature? Biotechnol. Bioeng. 91, 180–189.PubMedCrossRefGoogle Scholar
  14. 14.
    Proudfoot, N. J., Furger, A., and Dye, M. J. (2002) Integrating mRNA processing with transcription. Cell 108, 501–512.PubMedCrossRefGoogle Scholar
  15. 15.
    Haussler, D. (1998) Computational genefinding. Trends Biochem. Sci. Suppl, 12–15.Google Scholar
  16. 16.
    Degroeve, S., De Baets, B., Van de Peer, Y., and Rouzé, P. (2002), Feature subsets selection for splice site prediction. Bioinformatics 18, S75-S83.PubMedGoogle Scholar
  17. 17.
    Lacy-Hulbert, A., Thomas, R., Li, X. P., Lilley, C. E., Coffin, R. S., and Roes, J. (2001) Interruption of coding sequences by heterologous introns can enhance the functional expression of recombinant genes. Gene Ther. 8, 649–653.PubMedCrossRefGoogle Scholar
  18. 18.
    Graf, F., Deml, L., and Wagner, R. (2004) Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA. Methods Mol. Med. 94, 197–210.PubMedGoogle Scholar
  19. 19.
    Wand, S., Farfan-Arribas, D.J., Shen, S., et al., (2006). Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 24, 4531–4540.CrossRefGoogle Scholar
  20. 20.
    Scholten, K. B., Kramer, D., Kueter, E. W., et al. (2006) Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin. Immunol. 119, 135–145.PubMedCrossRefGoogle Scholar
  21. 21.
    Whittle, N., Adair, J., Lloyd, C., et al. (1987) Expression in COS cells of a mouse-human chimaeric B72.3 antibody. Protein Eng. 1 499–505.PubMedCrossRefGoogle Scholar
  22. 22.
    Bebbington, C. R., Renner, G., Thomson, D., King, D., Abrams, D., and Yarranton, G. T. (1992) Highlevel expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio. Technol. 10, 169–175.Google Scholar
  23. 23.
    Schlatter S., Stansfield, S. H., Dinnis, D. M., Racher, A. J., Birch, J. R., and James, D. C. (2005), On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol. Prog. 21, 122–133.PubMedCrossRefGoogle Scholar
  24. 24.
    Yoo, E. H., Chintalacharuvu, K. R., Penichet, M. L., and Morrison, S. L. (2002) Myeloma expression systems. J. Immunol. Methods 261, 1–20.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  1. 1.Lonza BiologicsSloughUK

Personalised recommendations